Naproxen: an aldose reductase inhibitor and potential anti-cataract agent.
Gupta
S K
SK
Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi.
Joshi
S
S
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D000818:Animals; D002386:Cataract / Q000188:drug therapy*; D004285:Dogs; D004376:Galactitol / Q000737:chemistry; D005690:Galactose / Q000494:pharmacology; D006041:Goats; D006801:Humans; D066298:In Vitro Techniques; D007908:Lens, Crystalline / Q000737:chemistry / Q000187:drug effects; D009288:Naproxen / Q000627:therapeutic use*; D009883:Ophthalmic Solutions; D051381:Rats; D013654:Taurine / Q000737:chemistry
D009883:Ophthalmic Solutions; D004376:Galactitol; D013654:Taurine; D009288:Naproxen; D000449:Aldehyde Reductase; D005690:Galactose